Table 1.
Demographic Characteristics | HIV + (N= 33) | HIV − (N= 33) | P-Value |
---|---|---|---|
Age (years) | 47 (45,48) | 47 (46,49) | 0.06 |
% older than median split | 33% (11) | 45% (15) | 0.31 |
Race: %(#) | |||
Non-White | 64% (21) | 52% (17) | 0.32 |
Hispanic Ethnicity | 15% (5) | 12% (4) | 0.72 |
Body Mass Index | 28.6±6.5 | 28.7±5.6 | 0.98 |
Current Smoker % (#) | 70% (23) | 42% (14) | 0.03* |
History of Substance Abuse % (#) | 76% (25) | 36% (12) | 0.001** |
Current Methadone use % (#) | 9% (3) | 6% (2) | 0.64 |
Current selective serotonin reuptake inhibitor (SSRI) use % (#) | 33% (11) | 18% (6) | 0.16 |
Menopause-Related Clinical Characteristics | |||
Total Number of Periods in the Past Year | 5 (4,9) | 6 (4,10) | 0.53 |
Experienced hot flashes 8 or more days in the past 4 weeks (range:0–28 days)† | 67% (22) | 42% (14) | 0.048* |
Follicle Stimulating Hormone (mIU/mL) †† | 24 (8,53) | 35 (15,63) | 0.19 |
Estradiol (pg/mL) ††† | 60 (32, 206) | 81 (44,154) | 0.61 |
(pmol/L) | 220 (118,756) | 297 (162,565) | |
HIV-Related Characteristics | |||
Duration of HIV (years) | 14± 6 | - | - |
Currently taking Antiretroviral Therapy % (#) | 91% (30) | - | - |
Current NRTI use | 91% (30) | - | - |
Current NNRTI use | 9% (3) | - | - |
Current PI use | 45% (15) | - | - |
CD4 count (#/mm3)†††† | 686±432 | - | - |
Nadir CD4 count (#/mm3)††††† | 199 (60,290) | - | - |
Data are reported as % (N) for categorical variables, and for continuous variables, as mean/SD or median (IQR=interquartile range) for data that were not normally distributed.
=P<0.05,
=P<0.01.
Median hot flash frequency split. Missing values are not included in the calculation: N=2,
Missing values not included in calculation: N=3,
Missing values not included in calculation: N=7,
Missing values not included in calculation: N=3. PI = protease inhibitor; NRTI = nucleoside reverse transcriptase inhibitor; NNRTI = non-nucleoside reverse transcriptase inhibitor.